← Open Payments lookup

DONALD DEARMAN: Open Payments

NPI 1679084024 · VICKSBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,824 in 118 payments from 13 companies in 2025. Trend: 2023 $790 · 2024 $1,484 · 2025 $1,824

Food & beverage: $1,824
CompanyPaymentsAmount
ABBVIE INC.19$315
Otsuka America Pharmaceutical, Inc.12$257
Axsome Therapeutics, Inc.12$201
E.R. Squibb & Sons, L.L.C.9$188
Alkermes, Inc.12$187
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$157
Lundbeck LLC7$129
Vanda Pharmaceuticals Inc.6$110
Janssen Pharmaceuticals, Inc6$109
Neurocrine BioSciences, Inc.4$99

Products named: REXULTI, VRAYLAR, Auvelity, COBENFY, CAPLYTA, FANAPT, INGREZZA, ARISTADA.

Industry payments across MS — which companies pay providers there.